T he left atrium (LA) plays an integral role in the pathophysiology and prognosis of heart failure with preserved ejection fraction (HFpEF). 1 As diastolic function worsens because of vascular and left ventricular (LV) stiffening, LV filling pressures increase, leading to LA pressure overload and enlargement.
value of LA strain in patients with HFpEF is not known. Furthermore, no previous studies have compared the prognostic utility of LA strain versus LV and right ventricular (RV) strain in HFpEF.
Therefore, we sought to (1) determine the clinical, invasive hemodynamic, and cardiopulmonary exercise testing (CPET) correlates of LA strain in HFpEF; and (2) evaluate the prognostic utility of LA strain in HFpEF and determine its significance when compared with conventional echocardiographic and clinical factors, and indices of LV and RV mechanics. We hypothesized that in HFpEF, decreased LA strain (indicative of worse LA function) is associated with worse hemodynamics and decreased peak oxygen consumption (VO 2 ); is associated with poor outcomes; and is a stronger correlate of adverse events than LV or RV strain.
Methods

Study Population
Between March 2008 and May 2011, consecutive patients were prospectively enrolled from the outpatient clinic of the Northwestern University HFpEF Program as a part of a systematic observational study of HFpEF (ClinicalTrials.gov; NCT01030991). All patients were enrolled into the study in the outpatient setting after a hospitalization for HF. Patients were initially identified by an automated daily query of the inpatient electronic medical record at Northwestern Memorial Hospital (at the time of hospitalization) using the following search criteria: (1) diagnosis of HF or the term HF in hospital notes, (2) B-type natriuretic peptide >100 pg/mL, or (3) administration of ≥2 doses of intravenous diuretics. Patients were offered postdischarge follow-up in a specialized HFpEF outpatient program if they met the following 3 inclusion criteria: age ≥21 years, LVEF ≥50%, and the presence of HF as defined by Framingham criteria. 10 Post hospitalization, the HF diagnosis was confirmed in the outpatient HFpEF clinic. All patients met the European Society of Cardiology criteria for the diagnosis of HFpEF. 11 Patients were excluded if they had more than moderate valvular disease, previous cardiac transplantation, previous history of a reduced LVEF <40% (ie, recovered EF), severe LV dilation (LV end-diastolic volume >97 mL/ m 2 ), or constrictive pericarditis. All study participants gave written informed consent, and the Institutional Review Board at Northwestern University approved the study.
Clinical Characteristics
We collected the following data in all study participants: demographics, New York Heart Association (NYHA) functional class, comorbidities, medications, vital signs, body mass index, and laboratory data, including creatinine, hemoglobin, and B-type natriuretic peptide. Estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease equation. Definitions of each of the individual comorbidities are listed in the Data Supplement.
Conventional Echocardiography
All study participants underwent comprehensive 2D echocardiography with Doppler and tissue Doppler imaging using commercially available ultrasound systems with harmonic imaging (Philips iE33 or 7500; Philips Medical Systems, Andover, MA; or Vivid 7; GE Healthcare, General Electric Corp, Waukesha, WI), as detailed in the Data Supplement.
Speckle-Tracking Echocardiography
All images used for speckle-tracking echocardiographic analysis were obtained at a frame rate of 50 to 70 fps. Strain was analyzed by a single investigator using a customized software package (2D Cardiac Performance Analysis, TomTec v4.5, Munich, Germany). Three consecutive cardiac cycles were recorded and averaged. Speckletracking analysis was not performed in patients with unacceptable image quality, defined as >1 segment dropout, missing view, or significant foreshortening of the LV, RV, or LA.
We used the ventricular cycle as the reference point (ie, zero baseline) to calculate LA strain. 2 Therefore, the onset of the QRS complex is the zero reference, and all longitudinal LA strain values are positive. We defined the following components of LA function (strain): LA reservoir strain=peak (maximal) longitudinal LA strain; LA booster strain=longitudinal LA strain measured between onset of the P wave and onset of the QRS complex; and LA conduit strain=LA reservoir strain-LA booster strain. In patients who were in atrial fibrillation at the time of echocardiography, there is no LA booster function because of the loss of coordinated LA contraction; in these cases, LA conduit strain=LA reservoir strain.
To generate LA strain curves, the LA endocardial border was manually traced in the apical 4-and 2-chamber views. The region of interest generated was subsequently adjusted to include the full thickness of the LA myocardium. In each patient, the software divided the LA into 6 separate segments, longitudinal strain curves were generated, and tracking was evaluated. Any segment that did not sufficiently track well was excluded from final analysis, and the remaining segments were averaged for each view. LA reservoir, booster, and conduit strains were calculated by averaging the apical 4-and 2-chamber strain values. In patients with atrial fibrillation at the time of echocardiography, speckle-tracking of the apical 4-and 2-chamber views was performed on 3 different beats, and LA strain values from the 3 beats were averaged in each view. LA stiffness index was calculated as the ratio of E/e′ to LA reservoir strain as previously defined. 5 In addition to LA strain, LV longitudinal strain and longitudinal RV free wall strain were also measured. The LV endocardial border was manually traced in the apical 4-and 2-chamber views, and the RV endocardial border traced in the apical 4-chamber RV-focused view. Similar to the LA, the software divided the LV and RV into 6 segments and regions with insufficient tracking were excluded. LV longitudinal strain was calculated by averaging the remaining segments for each view, and RV free wall strain was calculated by averaging the 3 RV free wall segments.
For ease of reporting and interpretation, all strain values were reported as absolute values (lower absolute strain values correspond to worse cardiac mechanics).
Invasive Hemodynamic Testing and Cardiopulmonary Exercise Testing
In subsets of the study participants, right-sided heart catheterization and symptom-limited CPET were performed as described in the Data Supplement.
Outcomes
After enrollment, study participants were evaluated in the Northwestern HFpEF Program at least every 6 months. At each visit, intercurrent hospitalizations were documented, reviewed, and categorized because of cardiovascular or noncardiovascular causes. Every 6 months, participants (or their proxy) who were not able to come into clinic were contacted to determine vital status with verification of deaths through query of the Social Security Death Index. Enrollment date was defined as the first visit to the outpatient HFpEF clinic. Date of last follow-up was defined as the date of death or last HFpEF clinic visit. Follow-up was complete in all patients. The primary end point was a combined outcome of cardiovascular hospitalization and death, which included hospitalization for any cardiovascular cause (including HF) and death from any cause.
Statistical Analysis
Intraobserver variability for LA strain was assessed in 15 randomly selected patients by having the same observer repeat the analysis 1 month apart. Interobserver variability for LA strain was assessed in 30 randomly selected patients by having the same observer and another experienced observer repeat the analysis. Reproducibility data were reported using intraclass correlation coefficients and coefficient of variation.
Clinical characteristics, laboratory data, echocardiographic measures, invasive hemodynamics, and CPET data were summarized for the entire cohort, and univariable Cox regression analyses were used to determine the association between these variables and adverse outcomes (cardiovascular hospitalization [which included HF hospitalization] or death). Next, we examined the correlation between indices of cardiac mechanics (LV, RV, and LA strain measures) and both invasive hemodynamics and CPET variables. These analyses were performed using a Pearson pairwise correlation. For the dependent variables, pulmonary artery (PA) systolic pressure, thermodilution cardiac output, pulmonary vascular resistance (PVR), and peak VO 2 , we used unadjusted and multivariable-adjusted linear regression analyses with LA reservoir strain as the independent variable. Covariates included age, sex, obesity, atrial fibrillation, LA volume, LV mass, and E/e′ ratio. Formal interaction testing with multiplicative interaction terms and the likelihood ratio test was used to determine whether clinical characteristics (age, sex, and comorbidities) modified the associations between LA reservoir strain and the aforementioned hemodynamic and CPET indices.
For survival analyses, we used Cox proportional hazards regression to evaluate the unadjusted relationship between the measures of LA function and outcomes. Models were then adjusted for covariates chosen based on a combination of clinical relevance and association with adverse outcomes in HFpEF. We used a series of models for our Cox regression analyses. After performing unadjusted analyses, we performed the following multivariable-adjusted analyses: model 1 included sex, atrial fibrillation, the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) risk score, LV mass, and LA volume; model 2 included model 1 covariates+E/e′ ratio; and model 3 included model 2 covariates+LV longitudinal strain and RV free wall strain. The MAGGIC risk score 12 is a mortality risk score for patients with HF, including those with HFpEF, and includes age, LVEF, creatinine, diabetes mellitus, chronic obstructive pulmonary disease, systolic blood pressure, body mass index, heart rate, NYHA functional class, angiotensin-converting enzyme inhibitor use, β-blocker use, HF duration, and current smoking.
To determine the relative utility of strain measures beyond conventional risk predictors, and to compare the prognostic and discriminative utility across strain measures, we used a combination of tests, including Harrell C-statistic, integrated discrimination improvement, net reclassification improvement, the likelihood ratio test, and Bayes information criterion.
In sensitivity analyses, we repeated linear and Cox regression analyses after excluding participants who had atrial fibrillation or moderate mitral regurgitation at the time of echocardiography. A 2-sided P<0.05 was considered to indicate statistical significance. All analyses were performed using Stata version 12 (StataCorp, College Station, TX).
Results
Baseline Clinical Characteristics
Of the 419 enrolled patients, echocardiographic images could not be retrieved in 56 patients. An additional 55 patients were excluded from the final analysis because of poor image quality for speckle-tracking strain analysis (feasibility=85%). Table 1 summarizes the clinical characteristics and the association of these characteristics with adverse events for the remaining 308 patients. The majority of patients were women, nearly half of the study sample was nonwhite (48%), and most patients (84%) had NYHA functional class II or III symptoms.
The median follow-up time was 13.8 months (25th-75th percentile, 4.5-23.9 months). During the follow-up period, 94 patients (31%) were hospitalized for a cardiovascular reason, 66 (21%) were hospitalized for HF, 37 (12%) died, and 115 (37%) experienced the composite end point of cardiovascular hospitalization (including HF hospitalization) or death.
Several clinical and laboratory characteristics were associated with adverse outcomes on univariable Cox regression analyses. Older age; worse NYHA functional class, systemic hypertension, chronic kidney disease, certain medications (loop diuretics, β-blockers, and nitrates); higher B-type natriuretic peptide; and lower hemoglobin were associated with adverse outcomes. In addition, a higher MAGGIC risk score was associated with adverse events. Table 2 summarizes the conventional echocardiographic, tissue Doppler, and speckle-tracking measures of the study cohort and their association with adverse events. Overall, patients had evidence of structural heart disease with high prevalence of LV hypertrophy (43%) or concentric remodeling (38%) and moderate or greater LV diastolic dysfunction (75%). Although LVEF was preserved overall (≥50% in all patients, with a mean value of 61±6%), tissue Doppler imaging s′ velocity and LV longitudinal strain were decreased in the study cohort. 13 Of the 308 study patients, 230 (75%) had abnormal absolute LV longitudinal strain (defined as absolute LV longitudinal strain <20% 14 ). The prevalence of RV systolic dysfunction was relatively low when defined by conventional echocardiographic measures (19% of patients had an RV fractional area change <35%; 26% of patients had a tricuspid annular plane systolic excursion <1.6 cm). However, when defined by RV free wall strain (absolute RV free wall strain, <20% 14 ), the prevalence of RV systolic dysfunction was higher (48% of patients).
Baseline Echocardiographic Characteristics, Including Speckle-Tracking LV and RV Longitudinal Strain Measures
A higher LV mass index and increased E/e′ ratio, consistent with pathological LV hypertrophy and elevated LV filling pressures, respectively, were associated with adverse outcomes. Lower tissue Doppler imaging s′ velocities, decreased (worse) LV longitudinal strain, and decreased (worse) RV free wall strain were also associated with adverse outcomes ( Table 2) .
Baseline LA Size and Function, Including Speckle-Tracking LA Strain Measures
On average, LA size, as measured by LV volume index, was dilated in the study population, and 67% of the study patients had evidence of LA enlargement (using a cutoff of >28 mL/ m 2 ). Figure 1 displays examples of LA strain curves in HFpEF patients with and without atrial fibrillation. Table I in the Data Supplement displays the intra-and interobserver variability of LA strain measures. The normal range for LA reservoir strain using TomTec strain software is not defined. However, based on published normal values for LA reservoir strain 15 using GE strain software, 26% of the patients had LA reservoir strain values <22.7%, which is 2 SDs below the mean in healthy controls (44.1%), and 56% of patients had LA reservoir strain values <34.1%, which is 1 SD below the mean in healthy controls.
Beat-to-beat variability was evaluated in patients with atrial fibrillation. The mean value for LA reservoir strain in LA Mechanics in HFpEF patients with atrial fibrillation at the time of echocardiography was 16.9%. The SD of LA reservoir strain measured across multiple beats was 1.7 units. The coefficient of variation for LA reservoir strain measured across multiple beats was 9.2%.
LA volume index was not associated with adverse outcomes during follow-up. However, lower septal and lateral tissue Doppler imaging a′ velocities (markers of the LA contribution to mitral annular motion at end-diastole) were associated with adverse events. In addition, as shown in Table 2 , decreased (worse) LA booster, conduit, and reservoir strain were all associated with adverse events. Increased LA stiffness was also associated with poor outcomes in the study sample. Table II in the Data Supplement displays the demographic, clinical, laboratory, and echocardiographic measures that were associated with LA booster, conduit, and reservoir strain. Several factors, including atrial fibrillation; increased B-type natriuretic peptide, MAGGIC risk score, LV mass, LA volume, and E/e′ ratio; and decreased glomerular filtration rate, tissue velocities were each associated with associated with worse LA strain values. LV longitudinal strain and RV free wall strain were associated with decreased (worse) LA strain, particularly LA reservoir strain. To determine the clinical utility of LV, RV, and LA strain measures, we also examined the association between strain measures and (1) invasive hemodynamics and (2) CPET variables. Several invasive hemodynamic and CPET variables, including right atrial pressure, PA pressure, and peak VO 2 , known to carry prognostic value in HF, were also associated with adverse events in our study ( Table III in the Data Supplement) .
Comparison of the Clinical and Prognostic Utility of LV, RV, and LA Strain
As shown Table III in the Data Supplement, LV longitudinal strain was only marginally associated with PA pressure, cardiac index, exercise workload, and ventilatory efficiency. RV free wall strain was associated with cardiac index and PVR, but was not associated with any CPET variables. However, LA reservoir strain was significantly associated with several Categorical variables are presented as counts and percentages; continuous variables are presented as mean±SD unless otherwise specified. ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BNP, B-type natriuretic peptide; CI, confidence interval; COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; MAGGIC, Meta-Analysis Global Group in Chronic Heart Failure; and NYHA, New York Heart Association.
*Hazard ratio is per 10-year increase. †Hazard ratio is per 1-SD increase. ‡Hazard ratio is per 1-SD decrease. On linear regression analyses, LA reservoir strain remained associated with PA systolic pressure and PVR after multivariable adjustment ( Table 3 ). We did not identify any interactions between clinical characteristics (eg, comorbidities) and LA reservoir strain for the association with PA systolic pressure or PVR. Figure 2 displays the relationship between quartiles of LA reservoir strain and PVR.
On multivariable-adjusted linear regression analyses, LA reservoir strain also remained associated with thermodilution cardiac output (measured invasively) and peak VO 2 (Table 3) . We found multiple significant interactions (P<0.05) for the association between LA reservoir strain and peak VO 2 . The association between LA reservoir strain and peak VO 2 was much stronger in those who were younger and in the absence of chronic obstructive pulmonary disease, obesity, chronic kidney disease, and diabetes mellitus. Figure 3 displays examples of the aforementioned interactions: Figure 3A shows the relationship between LA strain and peak VO 2 , stratified by median age (65 years); Figure 3B shows the same relationship stratified by the presence or absence of obesity. Table IV in the Data Supplement shows that exclusion of patients with either atrial fibrillation (n=39) or moderate mitral regurgitation (n=36) at the time of echocardiography did not eliminate most of the associations between LA reservoir strain and invasive hemodynamic and CPET measures. LA reservoir strain was still associated with cardiac index, PVR, and peak VO 2 after multivariable adjustment. 
Table 2. Summary of Echocardiographic, Invasive Hemodynamic, and Cardiopulmonary Exercise Test Characteristics of the Study Cohort, and Association of These Characteristics With Cardiovascular Hospitalization or Death on Cox Regression Analysis
Association of Indices of Cardiac Mechanics With Outcomes on Cox Regression Analysis
In unadjusted Cox proportional hazards models, all indices of cardiac mechanics were associated with adverse outcomes (Table 4 ). On the basis of hazard ratios per 1-SD worsening of indices of cardiac mechanics, LA reservoir strain was most closely associated with adverse events, followed by LA conduit and booster strains. After multivariable adjustment for several demographic, clinical, and echocardiographic variables (including LV and RV longitudinal strain), both LA reservoir and booster strains still remained associated with adverse outcomes. Further adjustment for the presence and severity of mitral regurgitation did not attenuate the association between LA strain and outcomes. The relationship between LA strain measures with the composite outcome of HF hospitalization, cardiovascular hospitalization, or death was relatively linear ( Figure I in the Data Supplement), especially for LA reservoir strain. Figure 4A displays the Kaplan-Meier curves for LA reservoir strain, stratified by the median value (31.2%). Figure 4B demonstrates that the Kaplan-Meier curves appeared similar when considering only patients without atrial fibrillation. 
Incremental Prognostic Utility of Indices of Cardiac Mechanics
As shown in Table VI in the Data Supplement, LA reservoir strain outperformed LV longitudinal strain and RV free wall strain in its prognostic and discriminative utility above and beyond traditional risk markers such as the MAGGIC risk score and LA volume. LA reservoir strain had the highest relative integrated discrimination improvement and increase in the C-statistic.
Discussion
In this study of a large, contemporary cohort of patients with HFpEF, we found that all components of LA strain (LA conduit, LA booster, and LA reservoir), as determined by speckle-tracking 2D echocardiography, were predictive of cardiovascular hospitalizations (including HF hospitalization) and death. In addition, LA reservoir strain remained strongly prognostic after adjustment for atrial fibrillation, LA volume, LV mass, and the MAGGIC risk score. Even after further adjustment for LV longitudinal strain and RV free wall strain, LA reservoir strain still retained its prognostic value. In addition, LA reservoir strain was more closely associated with PVR and VO 2 than LV and RV strain. To our knowledge, our study is the first to clearly demonstrate the central clinical and prognostic importance of LA strain in HFpEF, above and beyond LV or LA structure, LV strain, and RV strain.
Prognostic Value of LA Function Compared With LA Size in HFpEF
Although multiple studies have provided evidence of the value of LA function for the diagnosis of HFpEF 5, 8, 9 and the role LA function plays in the pathophysiology of HFpEF, 16, 17 our study is the first to show the powerful prognostic role of LA strain in this patient population. Earlier publications showed that indexed LA volume is a robust correlate of adverse events including incident HF in patients with normal LVEF 18 and incident atrial arrhythmia in people aged ≥65 years. 19 However, these studies did not measure LA function using speckletracking analysis.
Our data are consistent with these recent publications and build on it by showing the improved ability of LA strain to predict adverse outcomes in patients with HFpEF when compared with LA size. This result underscores the idea that indexed LA volume is simply a surrogate of LV filling pressures and more accurately reflects an adaptive change to the increased pressure rather than the intrinsic LA myocardial abnormalities that occur with HFpEF. This is particularly true in our patient population in which the overall severity of symptoms (46% NYHA class III) and enlarged LA in the majority of patients (67%) makes LA size alone a relatively poor marker for predicting adverse events.
Prognostic Value of LA Function Compared With Other Strain Measures
We also found that in patients with HFpEF, speckle-tracking strain of the LA is a more powerful correlate of adverse outcomes than LV and RV longitudinal strain. Using a variety of metrics, we show convincingly that of the speckle-tracking indices of longitudinal cardiac mechanics, LA strain is most associated with future risk of adverse events. Although exclusion of patients with moderate mitral regurgitation and atrial fibrillation attenuated the significant association between LA strain and adverse outcomes in the fully adjusted multivariable analysis (model 3), LA booster and reservoir strains were still associated with adverse outcomes after adjustment for all variables except LV and RV longitudinal strains (model 2) in this subgroup. Furthermore, LA reservoir strain in this subgroup retained significance in a model including only LA reservoir strain, LV longitudinal strain, and RV free wall strain (P<0.001 on Cox regression analyses).
Only 1 previous study compared the prognostic roles of LA and LV strain using speckle-tracking echocardiography. 20 This study demonstrated that LV longitudinal strain was a better correlate of death and cardiovascular hospitalization than LA function in patients with acute myocardial infarction. The different patient populations studied most likely explain the discrepancy in these results as ischemia affects LV longitudinal strain to a greater extent in patients with acute myocardial infarction than in patients with HFpEF.
The finding that LA strain is a more powerful correlate of outcomes than LV and RV longitudinal strain is meaningful because multiple pathophysiologic factors contribute to the HFpEF syndrome. 21 LA reservoir function is considerably influenced by LA relaxation and compliance. In HFpEF, myocardial fibrosis of the LA likely plays a significant role in disease progression as it does in patients with atrial fibrillation 22 and severe mitral regurgitation. 23 This is evident in our study by the significantly higher LA stiffness index in patients who experienced adverse events during follow-up. The subsequent remodeling of the LA myocardium decreases LA compliance and blunts LA reservoir function in response to increases in preload. 9 Table 3 
. Association of Left Atrial Reservoir Strain With Selected Invasive Hemodynamic and Cardiopulmonary Exercise Testing Measures on Linear Regression Analysis
Abnormal LA Function: A Key Stimulus for Elevated PVR and Reduced Exercise Capacity in HFpEF
Several pathophysiologies exist in patients with HFpEF, and each of these may result in reduced exercise capacity and worse outcomes. HFpEF patients with elevated PVR and right HF are particularly vulnerable to worse outcomes, and the factors that lead to these pathophysiologic abnormalities are unclear. Our study indicates that abnormal LA mechanics, more so than E/e′ ratio or LA volume, may be indicative of significant chronic LA pressure and volume overload with subsequent chronic pulmonary venous congestion, ultimately resulting in pulmonary vasoconstriction and decreased PA compliance. In a smaller study (n=101) that examined LA EF in HFpEF, Melenovsky et al 24 also found an association between LA function and PVR; however, this study did not control for E/e′ or LA volume, did not measure LA strain, and did not compare LA mechanics to LV mechanics in relationship to PVR. In addition, because of the smaller number of patients, this study was limited by an inability to perform multivariable adjustment for LA size or history of atrial fibrillation. The association of LA reservoir strain and peak VO 2 suggests that worse LA mechanics leads to poor augmentation of cardiac output with exertion and decreased exercise tolerance. As shown in Figure 3 , the results of our statistical interaction testing analysis demonstrate abnormal LA mechanics is especially important in younger patients with less comorbidities because these individuals are less likely to have extracardiac reasons for exercise intolerance (such as aging-related musculoskeletal problems or obesity).
Potential Therapeutic Implications of LA Dysfunction in HFpEF
The findings of our study point to a potential central role of abnormal LA mechanics in the HFpEF syndrome. Speckletracking LA strain measures, already known to be useful for the diagnosis of HFpEF, may also be useful in understanding responsiveness to pharmacological and device-based therapies. Indeed, in response to the growing recognition of the critical role the LA plays in the pathophysiology of HFpEF, new devices to unload and decompress the LA are increasingly becoming available. An interatrial shunt device to decrease LA pressure is currently being studied in controlled trials. 25 Another potential therapeutic strategy in advanced HFpEF patients is a LA assist device. 26 Additional study is necessary to determine whether improvement in LA mechanics could lead to decreased PVR, increased cardiac output, and increased exercise capacity.
Strengths and Limitations
The strengths of our study include the prospective and standardized recruitment of high-risk patients with HFpEF, the large number of patients included in the final analysis (with high feasibility of speckle-tracking echocardiography), and the prognostic comparison of LA strain with LV and RV strain measures. Furthermore, in relatively large subsets of patients, we were able to examine the associations between LA strain measures and invasive hemodynamics and CPET variables, thereby providing pathophysiological insight into the importance of LA strain in HFpEF. Finally, the sample size and number of events allowed us to perform comprehensive multivariable adjustment to clearly show the prognostic utility of LA mechanics in HFpEF.
Nevertheless, certain limitations should also be considered when interpreting our results. First, strain acquisition was not possible in 55 patients. However, we were able to perform speckle-tracking analysis on the majority (85%) of the study participants and reproducibility was excellent. Strain analysis was also performed by averaging all 6 segments of the LA endocardium in only 2 imaging planes. Other studies have used 3 imaging planes, and some have consistently excluded the posterior LA. Currently, there is no standardization of LA strain acquisition. Three-dimensional speckle-tracking strain might have overcome some of the limitations in LA strain analysis, but this technique is not widely used, and there are limited data to support the use of this method. Second, the cutoff values for abnormal strain values-particularly for LA strain using TomTec software-are not well defined, and our study did not include a control group. Thus, the prevalences of abnormal LV, RV, and LA strain in our cohort should be interpreted with caution. Third, patients with either atrial fibrillation or moderate mitral regurgitation, both of which can affect LA mechanics, were included in our primary analyses. However, we adjusted for these factors in our multivariable analyses, and the associations of LA strain with PVR, peak VO 2 , and adverse outcomes persisted. In addition, we performed sensitivity analyses after excluding patients with atrial fibrillation or moderate mitral regurgitation at the time of echocardiography. Finally, the associations identified in the present study cannot prove causation given our study design and the possibility of unmeasured confounders in regression analyses.
Conclusions
In patients with HFpEF, indices of LA mechanics-particularly LA reservoir strain-are independently associated with adverse outcomes. LA reservoir strain is the speckle-tracking measure most associated with elevated PVR, decreased cardiac output, reduced exercise capacity, and the increased risk of the combined end point of cardiovascular hospitalization or death. Given these findings, novel therapeutic options for unloading the LA and augmenting its function may be beneficial in HFpEF. 
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